With dozens of new startups underway and the imminent opening of a state-of-the-art biotech incubator at 101 College Street — a burgeoning ecosystem of innovation and entrepreneurship nurtured by Yale and city leaders — New Haven has positioned itself as...
Since the 1960s, the hallucinogenic drug ibogaine has piqued interest as a potential treatment for opioid addiction, fueled by limited experimental evidence and anecdotal claims by those who claim they no longer felt a craving for opioids after taking...
When it was launched in April 2003, the Human Genome Project helped revolutionize biomedical research by providing scientists a reference map that allowed them to analyze DNA sequences for genetic clues to the origins of a host of diseases.
Twenty years...